- Drug Pipelines
- January 2024
- 90 Pages
Global
From €1928EUR$2,000USD£1,649GBP
- Report
- May 2024
- 50 Pages
Global
From €2555EUR$2,650USD£2,185GBP
- Drug Pipelines
- November 2023
- 30 Pages
United States
From €2651EUR$2,750USD£2,267GBP
- Report
- February 2023
- 260 Pages
Global
From €2699EUR$2,800USD£2,309GBP
- Drug Pipelines
- September 2022
- 280 Pages
Global
From €2314EUR$2,400USD£1,979GBP
- Report
- February 2024
- 80 Pages
India
From €4579EUR$4,750USD£3,917GBP
- Report
- April 2023
- 110 Pages
Global
From €4579EUR$4,750USD£3,917GBP
- Report
- April 2023
- 110 Pages
Global
From €4579EUR$4,750USD£3,917GBP
- Report
- April 2023
- 120 Pages
Global
From €4579EUR$4,750USD£3,917GBP
- Report
- July 2021
- 111 Pages
Global
From €4579EUR$4,750USD£3,917GBP
- Drug Pipelines
- December 2022
- 100 Pages
Global
From €2651EUR$2,750USD£2,267GBP
- Report
- August 2022
- 30 Pages
Global
From €2651EUR$2,750USD£2,267GBP
- Report
- July 2022
- 100 Pages
Global
From €2651EUR$2,750USD£2,267GBP
- Report
- August 2023
- 79 Pages
Egypt
From €3374EUR$3,500USD£2,886GBP
- Report
- January 2023
- 50 Pages
China
From €2892EUR$3,000USD£2,474GBP
- Report
- March 2023
- 151 Pages
Global
From €2410EUR$2,500USD£2,061GBP
- Report
- July 2022
- 225 Pages
Global
From €3471EUR$3,600USD£2,968GBP
- Report
- May 2022
- 80 Pages
Asia Pacific
From €1446EUR$1,500USD£1,237GBP
- Report
- May 2022
- 80 Pages
Europe
From €1446EUR$1,500USD£1,237GBP
- Report
- September 2023
- 24 Pages
Indonesia
From €825EUR$917USD£730GBP
The Ibuprofen market is a segment of the Over the Counter (OTC) Drugs industry. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain, fever, and inflammation. It is available in a variety of forms, including tablets, capsules, gels, creams, and liquids. Ibuprofen is one of the most widely used OTC drugs, and is available in both generic and branded forms. It is often used to treat mild to moderate pain, as well as inflammation associated with arthritis and other conditions. Ibuprofen is also used to reduce fever and to treat menstrual cramps.
The Ibuprofen market is highly competitive, with a number of major players. Some of the leading companies in the market include Johnson & Johnson, Bayer, Pfizer, GlaxoSmithKline, and Novartis. Show Less Read more